| Literature DB >> 22550543 |
Ahmed S Alrashdi1, Suzy M Salama, Salim S Alkiyumi, Mahmood A Abdulla, A Hamid A Hadi, Siddig I Abdelwahab, Manal M Taha, Jamal Hussiani, Nur Asykin.
Abstract
Jasminum sambac is used in folk medicine as the treatment of many diseases. The aim of the present investigation is to evaluate the gastroprotective effects of ethanolic extracts of J. sambac leaves against acidified ethanol-induced gastric ulcers in rats. Seven groups of rats were orally pre-treated with carboxymethylcellulose (CMC) as normal group, CMC as ulcer group, 20 mg/kg of omeprazole as positive group, 62.5, 125, 250, and 500 mg/kg of extract as the experimental groups, respectively. An hour later, CMC was given orally to normal group and acidified ethanol solution was given orally to the ulcer control, positive control, and the experimental groups. The rats were sacrificed after an hour later. Acidity of gastric content, the gastric wall mucus, ulcer areas, and histology and immunohistochemistry of the gastric wall were assessed. Gastric homogenates were determined for prostaglandin E(2) (PGE(2)), superoxide dismutase (SOD), andmalondialdehyde (MDA) content. Ulcer group exhibited significantly severe mucosal injury as compared with omeprazole or extract which shows significant protection towards gastric mucosal injury the plant promotes ulcer protection as it shows significant reduction of ulcer area grossly, and histology showed marked reduction of edema and leucocytes infiltration of submucosal layer compared with ulcer group. Immunohistochemistry showed overexpression of Hsp70 protein and downexpression of Bax protein in rats pretreated with extract. Significant increased in the pH, mucus of gastric content and high levels of PGE(2), SOD and reduced amount of MDA was observed.Entities:
Year: 2012 PMID: 22550543 PMCID: PMC3329065 DOI: 10.1155/2012/786426
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Histological sections of the liver and kidney from the acute toxicity test. (a and b) Rats treated with 5 mL/kg of the vehicle (CMC). (c and d) Rats treated with 2000 mg/kg (5 mL/kg) of the J. sambac extract. (e and f) Rats treated with 5000 mg/kg (5 mL/kg) of the J. sambac extract. There is no significant difference in the structures of the livers and kidneys between the treated and control groups (Hematoxylin and Eosin stain, 20× magnifications).
Figure 2Gross appearance of the gastric mucosa in rats. (a) Rats pretreated with 5 mL/kg CMC (normal control). No injuries to the gastric mucosa are seen. (b) Rats pretreated with 5 mL/kg CMC (ulcer control). Severe injuries are seen in the gastric mucosa. HCl/ethanol produced extensive visible hemorrhagic necrosis of gastric mucosa. (c) Rats pretreated with omeprazole (20 mg/kg). Injuries to the gastric mucosa are milder compared to the injuries seen in the ulcer control rats. (d). Rat pretreated with J. sambac extract (62.50 mg/kg). Moderate injuries are seen in the gastric mucosa. The extract reduces the formation of gastric lesions induced by acidified ethanol. (e). Rat pretreated with J. sambac extract (125 mg/kg). Moderate injuries are seen in the gastric mucosa. The extract reduces the formation of gastric lesions induced by acidified ethanol (f). Rat pretreated with J. sambac extract (250 mg/kg). Mild injuries are seen in the gastric mucosa. The extract reduces the formation of gastric lesions induced by acidified ethanol. (g) rats pretreated with 500 mg/kg of J. sambac extract. No injuries to the gastric mucosa are seen instead flattening of gastric mucosa is seen.
Figure 3(a) Effect of J. sambac on GMW. (b) Effect of J. sambac on pH of gastric content. (c) Effect of J. sambac on Ulcer area and inhibition %.
Figure 4Histological study of HCl/ethanol-induced gastric mucosal damage in rats. (a) Rats pretreated with 5 mL/kg of CMC (Normal control group). No injuries to the gastric mucosa are seen. (b) Rats pretreated with 5 mL/kg of CMC (ulcer control group). There is severe disruption to the surface epithelium and necrotic lesions penetrating deeply into mucosa and extensive edema of submucosa layer and leucocytes infiltration is present. (c) Rats pretreated with omeprazole (20 mg/kg). Mild disruption of the surface epithelium mucosa is seen. There is edema and leucocytes infiltration of the submucosal layer. (d) Rat pretreated with J. sambac extract (62.50 mg/kg). Moderate disruption of surface epithelium is present. There is submucosal edema and leucocytes infiltration. (e) Rats pretreated with J. sambac extract (125 mg/kg). There is mild disruption to the surface epithelium. There is edema with leucocytes infiltration of the submucosal layer. (f). Rats pretreated with J. sambac extract (250 mg/kg). There is mild disruption to the surface epithelium. There is no edema or leucocytes infiltration of the submucosal layer. (g) Rats pretreated with J. sambac extract (500 mg/kg). There is no disruption to the surface epitheliumand no edema or leucocytes infiltration of the submucosal layer (H&E stain 10×).
Figure 5Immunohistochemical analysis of expression of Hsp and Bax proteins in the stomach of rats in HCl/ethanol-induced gastric ulcer. Immunohistochemistry staining of Hsp70 and Bax proteins showed overexpression of Hsp70 protein and downexpression of Bax protein in rats pretreated with plant extract (magnification 10×).
Figure 6(a) Effect of J. sambac leaf extract on PGE2 in gastric tissue homogenate. (b) Effect of J. sambac leaf extract on SOD in gastric tissue homogenate. (c) Effect of J. sambac leaf extract on MDA in gastric tissue homogenate.
(a)
| Dose | Sodium (mmol/L) | Pottasium (mmol/L) | Chloride (mmol/L) | CO2 (mmol/L) | Anion gap (mmol/L) | Urea (mmol/L) | Creatinine ( |
|---|---|---|---|---|---|---|---|
| Vehicle (CMC) | 141.33 ± 0.58 | 4.98 ± 0.04 | 103.88 ± 0.82 | 24.12 ± 0.54 | 18.75 ± 0.46 | 5.45 ± 0.45 | 34.83 ± 2.17 |
| LD (2 g/kg) | 142.05 ± 0.55 | 5.02 ± 0.09 | 105.29 ± 1.02 | 22.67 ± 0.81 | 18.55 ± 0.62 | 6.06 ± 0.83 | 33.87 ± 2.29 |
| HD (5 g/kg) | 143.14 ± 0.68 | 4.91 ± 0.06 | 104.35 ± 0.54 | 23.90 ± 0.64 | 19.15 ± 0.45 | 5.63 ± 0.37 | 35.05 ± 2.26 |
(b)
| Dose | Sodium (mmol/L) | Pottasium (mmol/L) | Chloride (mmol/L) | CO2 (mmol/L) | Anion gap (mmol/L) | Urea (mmol/L) | Creatinine ( |
|---|---|---|---|---|---|---|---|
| Vehicle (CMC) | 141.87 ± 0.42 | 4.83 ± 0.14 | 105.78 ± 0.67 | 23.33 ± 0.41 | 18.00 ± 0.25 | 7.95 ± 0.33 | 41.76 ± 2.75 |
| LD (2 g/kg) | 142.07 ± 0.56 | 4.55 ± 0.16 | 105.85 ± 0.65 | 22.65 ± 0.42 | 17.49 ± 0.46 | 7.97 ± 0.49 | 42.00 ± 2.36 |
| HD (5 g/kg) | 142.15 ± 0.47 | 4.63 ± 0.18 | 107.03 ± 0.53 | 21.96 ± 0.75 | 17.67 ± 0.48 | 8.31 ± 0.68 | 43.13 ± 2.24 |
Values expressed as mean ± S.E.M. There are no significant differences between groups. Significant value at P < 0.05.
(c)
| Dose | Total protein (g/L) | Albumin (g/L) | Globulin (g/L) | TB ( | CB ( | AP | ALT | AST | GGT |
|---|---|---|---|---|---|---|---|---|---|
| Vehicle (CMC) | 60.45 ± 1.25 | 9.62 ± 0.49 | 52.02 ± 1.40 | 2.17 ± 0.17 | 1.00 ± 0.00 | 153.00 ± 6.35 | 50.08 ± 1.62 | 172.95 ± 6.13 | 3.26 ± 0.25 |
| LD (2 g/kg) | 58.86 ± 0.86 | 8.81 ± 0.38 | 50.71 ± 1.21 | 2.13± 0.16 | 1.00 ± 0.00 | 154.17 ± 8.10 | 48.33 ± 0.58 | 174.23 ± 5.14 | 3.65 ± 0.42 |
| HD (5 g/kg) | 60.15 ± 1.05 | 9.17 ± 0.46 | 50.33 ± 1.24 | 2.02 ± 0.13 | 1.00 ± 0.00 | 155.00 ± 7.04 | 47.87 ± 1.55 | 175.15 ± 7.02 | 3.37 ± 0.18 |
(d)
| Dose | Total protein (g/L) | Albumin (g/L) | Globulin (g/L) | TB | CB | AP | ALT | AST | GGT |
|---|---|---|---|---|---|---|---|---|---|
| Vehicle (CMC) | 64.33 ± 1.26 | 11.19 ± 0.17 | 53.17 ± 1.28 | 2.00 ± 0.00 | 1.00 ± 0.00 | 108.83 ± 4.13 | 43.17 ± 2.91 | 171.83 ± 6.38 | 3.67 ± 0.33 |
| LD (2 g/kg) | 63.75 ± 1.19 | 11.05 ± 0.45 | 52.33 ± 1.26 | 2.00 ± 0.00 | 1.00 ± 0.00 | 98.83 ± 5.25 | 42.96 ± 2.70 | 172.17 ± 6.35 | 3.50 ± 0.51 |
| HD (5 g/kg) | 65.02 ± 2.65 | 11.30 ± 0.43 | 53.02 ± 1.25 | 2.00 ± 0.00 | 1.00 ± 0.00 | 102.67 ± 5.17 | 44.02 ± 1.85 | 174.28 ± 5.26 | 3.22 ± 0.44 |
Values expressed as mean ± S.E.M. There are no significant differences between groups. Significant value at P < 0.05.
TB: total bilirubin; CB: conjugated bilirubin; AP: alkaline phosphatase; ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: G-glutamyl transferase.